Bmi-1: At the crossroads of physiological and pathological biology
- PMID: 26448339
- PMCID: PMC4593320
- DOI: 10.1016/j.gendis.2015.04.001
Bmi-1: At the crossroads of physiological and pathological biology
Erratum in
-
Corrigendum to 'Bmi-1: At the crossroads of physiological and pathological biology' [Genes & Diseases 2 (2015) 225-239].Genes Dis. 2015 Dec 8;2(4):353. doi: 10.1016/j.gendis.2015.11.001. eCollection 2015 Dec. Genes Dis. 2015. PMID: 30258874 Free PMC article.
Abstract
Bmi-1 is a member of the Polycomb Repressor Complex1 that mediates gene silencing by regulating chromatin structure and is indispensable for self-renewal of both normal and cancer stem cells. Despite three decades of research that have elucidated the transcriptional regulation, post-translational modifications and functions of Bmi-1 in regulating the DNA damage response, cellular bioenergetics, and pathologies, the entire potential of a protein with such varied function remains to be realized. This review attempts to synthesize the current knowledge on Bmi-1 with an emphasis on its role in both normal physiology and cancer. Additionally, since cancer stem cells are emerging as a new paradigm for therapy resistance, the role of Bmi-1 in this perspective is also highlighted. The wide spectrum of malignancies that implicate Bmi-1 as a signature for stemness and oncogenesis also make it a suitable candidate for therapy. Nonetheless new approaches are vitally needed to further characterize physiological roles of Bmi-1 with the long-term goal of using Bmi-1 as a prognostic marker and a therapeutic target.
Keywords: Aging; BMI1; Cancer; Post translational modification; Stem cell.
Figures


References
-
- van Lohuizen M., Verbeek S., Scheijen B., Wientjens E., van der Gulden H., Berns A. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell. 1991;65:737–752. - PubMed
-
- Alkema M.J., Wiegant J., Raap A.K., Berns A., van Lohuizen M. Characterization and chromosomal localization of the human proto-oncogene BMI-1. Hum Mol Gene. 1993;2:1597–1603. - PubMed
-
- Raaphorst F.M. Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors. Hum Mol Genet. 2005;14(Spec No 1):R93–R100. - PubMed
-
- van der Lugt N.M., Domen J., Linders K. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev. 1994;8:757–769. - PubMed
-
- Li Z., Cao R., Wang M., Myers M.P., Zhang Y., Xu R.M. Structure of a Bmi-1-Ring1B polycomb group ubiquitin ligase complex. J Biol Chem. 2006;281:20643–20649. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources